BridgeMD
New treatment option for Hidradenitis Suppurativa
Official title A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
ClinicalTrials.gov ID: NCT07228390
What this study is testing
What is Ritlecitinib?
Ritlecitinib is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for hidradenitis suppurativa.
Also referred to as Investigational Product.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to learn about the safety and effects of the study medicine (called Ritlecitinib) for the possible treatment of hidradenitis suppurativa (HS). HS is a disease causing long lasting painful red skin lumps.
- Phase 2: a mid-size study of how well it works
- Time commitment: about 24 weeks
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Key Eligibility Criteria:
- Male or female participants ≥18 to ≤75 years of age.
- Participants with a diagnosis (based on clinical history and physical examination) of moderate to severe HS for at least 6 months prior to Screening...
You likely can't join if
- Presence of ≥20 draining fistulae at Screening or BL visit
- Evidence of other active skin disease or condition at screening
- Have a known immunodeficiency disorder
- Having a history of systemic infection requiring hospitalization or parenteral therapy, including history of infection with Mycobacterium TB
- Specific Viral Infection History (incl. history of herpes zoster, HBV or HCV Infection
- Current or recent history of clinically significant severe, progressive, or uncontrolled other medical conditions
See the full eligibility criteria
- Key Eligibility Criteria:
- Male or female participants ≥18 to ≤75 years of age.
- Participants with a diagnosis (based on clinical history and physical examination) of moderate to severe HS for at least 6 months prior to Screening Visit and inadequate response to at least 4-week (28 days) treatment...
- Presence of ≥20 draining fistulae at Screening or BL visit
- Evidence of other active skin disease or condition at screening
- Have a known immunodeficiency disorder
- Having a history of systemic infection requiring hospitalization or parenteral therapy, including history of infection with Mycobacterium TB
- Specific Viral Infection History (incl. history of herpes zoster, HBV or HCV Infection
- Current or recent history of clinically significant severe, progressive, or uncontrolled other medical conditions
- Any medical or psychiatric condition including any active suicidal ideation in the past year or suicidal behavior in the past 5 years
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Scottsdale, Arizona, United States
- Hot Springs, Arkansas, United States
- Fountain Valley, California, United States
- La Habra, California, United States
- Northridge, California, United States
- Sacramento, California, United States
- Santa Ana, California, United States
- Boca Raton, Florida, United States
- Largo, Florida, United States
- North Miami Beach, Florida, United States
- Tamarac, Florida, United States
- Tampa, Florida, United States
- Wellington, Florida, United States
- Sandy Springs, Georgia, United States
- Skokie, Illinois, United States
- Indianapolis, Indiana, United States
- Plainfield, Indiana, United States
- West Lafayette, Indiana, United States
- Overland Park, Kansas, United States
+ 37 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 24 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Scottsdale, Arizona, United States; Hot Springs, Arkansas, United States; Fountain Valley, California, United States; La Habra, California, United States; Northridge, California, United States and 51 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.